COMMUNIQUÉS West-GlobeNewswire

Syneos Health to Present at Upcoming Barclays Global Healthcare Conference

06/03/2018 - 23:30

RALEIGH, N.C., March 06, 2018 (GLOBE NEWSWIRE) -- Syneos Health TM (Nasdaq: SYNH ), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Alistair Macdonald is [...]

IHMA Completes the Globalization of its Two Laboratories with the Recent College of American Pathologists (CAP) Accreditation of IHMA Europe, Enhancing Support for Clinical Trials in Anti-Infective Drug Development and Global Surveillance Studies

06/03/2018 - 23:20

SCHAUMBURG, Ill., March 06, 2018 (GLOBE NEWSWIRE) -- On 14th October 2017 IHMA Europe Sàrl, located in Monthey, Valais, Switzerland, was awarded accreditation by the College of American Pathologists (CAP). With this [...]

REVA to Present at Cowen and Company 38th Annual Health Care Conference

06/03/2018 - 23:07

SAN DIEGO, March 06, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) is pleased to announce that its Chief Financial Officer, Ms. Brandi Roberts, is scheduled to present at the Cowen and [...]

iKang Schedules 2017 Unaudited Third Quarter Earnings Release on March 22, 2018

06/03/2018 - 23:00

BEIJING, March 06, 2018 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG ), major provider in China’s fast-growing private preventive healthcare services market, today announced [...]

Proteon Therapeutics to Present at Two Upcoming Investor Conferences

06/03/2018 - 22:45

WALTHAM, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq: PRTO ), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular [...]

Tetraphase Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results, Highlights Achievements and Key 2018 Milestones

06/03/2018 - 22:40

Achieved positive results of Eravacycline in Phase 3 IGNITE 4 clinical trial for cIAI Filed NDA in US for IV Eravacycline for cIAI and PDUFA date is August 28 th Raised over $65 million through underwritten equity [...]

ReWalk Robotics to Present at Upcoming Healthcare Conferences

06/03/2018 - 22:30

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK ) (“ReWalk” or “the Company”) today announced that Larry Jasinski, Chief Executive Officer, will present [...]

Switching clocks can wreak havoc on our sleep patterns

06/03/2018 - 22:26

CALGARY, Alberta, March 06, 2018 (GLOBE NEWSWIRE) -- Charles H. Samuels MD, CCFP, DABSM President, Canadian Sleep Society, Medical Director, Centre for Sleep and Human Performance Daylight Savings Time begins this [...]

Reprocessed VNUS ClosureFast Catheters – 6 Years of Superior Performance

06/03/2018 - 22:23

WATERBURY, Conn., March 06, 2018 (GLOBE NEWSWIRE) -- Northeast Scientific Inc. (NES) has released 5-year results proving that the use of their reprocessed medical devices is safe, effective and smart. NES has [...]

Aeglea BioTherapeutics to Present Adult Repeat Dose Data at 2018 Annual Meeting of The Society for Inherited Metabolic Disorders

06/03/2018 - 22:21

AUSTIN, Texas, March 06, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE ), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with [...]

Globus Medical Enters Trauma Market

06/03/2018 - 22:15

AUDUBON, Pa., March 06, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED ), a leading musculoskeletal solutions company, is pleased to announce its entry into the orthopedic trauma market. Globus Medical has [...]

Supernus to Present at the 2018 Cowen Health Care Conference

06/03/2018 - 22:15

ROCKVILLE, Md., March 06, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN ), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central [...]

Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

06/03/2018 - 22:05

WAYNE, Pa., March 06, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led, biopharmaceutical company focused on identifying, developing and commercializing innovative and [...]

TRACON Pharmaceuticals to Present at 30th Annual ROTH Conference

06/03/2018 - 22:05

SAN DIEGO, March 06, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]

Zafgen Reports Fourth Quarter and Full Year 2017 Financial Results; Announces Positive Interim Data from Ongoing ZGN-1061 Phase 2 Proof-of-Concept Trial in Patients with Type 2 Diabetes

06/03/2018 - 22:05

ZGN-1061 interim data suggest compound is safe and well-tolerated; no safety signals and placebo-like side effect profile ZGN-1061 interim efficacy data indicate significant A1C lowering vs. placebo at 8 weeks ZGN-1258 [...]

Portola Pharmaceuticals to Present at Two Upcoming Investor Conferences

06/03/2018 - 22:05

SOUTH SAN FRANCISCO, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA ) today announced that Bill Lis, chief executive officer, will present at the following conferences in March [...]

Atara Biotherapeutics to Present at the Cowen and Company 38th Annual Health Care Conference

06/03/2018 - 22:05

SOUTH SAN FRANCISCO, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, [...]

National Coordination Center to Support VA EMR with Resources from Top U.S. Health Care Organizations

06/03/2018 - 22:01

WASHINGTON, March 06, 2018 (GLOBE NEWSWIRE) -- The founding members of the National Coordination Center's Department of Veterans Affairs (VA) Steering Committee today announced their commitment to help support the VA’s [...]

Clearside Announces Proposed Public Offering of Common Stock

06/03/2018 - 22:01

ALPHARETTA, Ga., March 06, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases [...]